We’re building the future of genomic medicines
by expanding what immune medicines can target
JURA Bio, Inc.
& transforming how therapies are made.
With our ML-guided end-to-end discovery & development platform, we harness a combination of synthetic biology & probabilistic machine learning to help us design, build, & test the next generation of genomic medicines at extraordinary scale.
With Partners:
JURA is proud to support the ongoing efforts on behalf of patients with understudied autoimmune diseases at ProjectClio.Org and at End Ankylosing Spondylitis.
Contact us:
-
For more information, or if you’re interested in finding out if there’s a role for you at JURA, please reach out to: team@jurabio.com
-
JURA at the VDC at University of Massachusetts, Boston
3rd Floor, Wheatley Building
100 Morrissey Boulevard
Boston, MA 02125 USA -
JURA at Massachusetts Biomedical Initiatives (MBI)
60 Prescott Street
Worcester, MA 01605 USA -
JURA at Switzerland Innovation Park at Novartis Campus
Lichtstrasse 35, 4056 Basel, Switzerland